Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.48 (
transcriptase
)
9,479
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a dopaminergic neurotoxin which inhibits mitochondrial complex I. 3-Nitropropionic acid (3-NPA) inhibits mitochondrial complex II and produces specific striatal lesions. In order to produce a combined striatal neuronal and dopaminergic afferent lesion, we administered both toxins simultaneously to the mouse. The combination brought about a lesion in the striatum that was not simply additive of the two combined toxins. Intriguingly, a group of striatal neurons became immunoreactive to tyrosine hydroxylase after day 1. Some of them were clearly visible up to the dendritic details. Immuno-electron microscopy indicated that the tyrosine hydroxylase-positive striatal neurons contained densely immunoreactive polyribosomes. Reverse
transcriptase
-polymerase chain reaction analysis indicated the up-regulation of tyrosine hydroxylase mRNA in the treated striatum. These neurons were also immunoreactive to aromatic L-amino acid decarboxylase.We conclude that the combined administration of MPTP and 3-
NPA
caused a more profound damage to the nigro-striatal dopaminergic system, and thus some striatal neurons capable of up-regulating tyrosine hydroxylase were induced to produce dopamine, probably to compensate for the dopamine depletion.
...
PMID:Neuronal ectopic expression of tyrosine hydroxylase in the mouse striatum by combined administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 3-nitropropionic acid. 1173 97
RNA-dependent RNA polymerase
6 (RDR6) is a core component of the small RNA biogenesis pathway, but its function in meiosis is unclear. Here, we report a new allele of
OsRDR6
(
Osrdr6-meiosis
[
Osrdr6-mei
]), which causes meiosis-specific phenotypes in rice (
Oryza sativa
). In
Osrdr6-mei
, meiotic double-strand break (DSB) formation is partially blocked. We created a biallelic mutant with more severe phenotypes,
Osrdr6-bi
, by crossing
Osrdr6-mei
with a knockout mutant,
Osrdr6-edit
In
Osrdr6-bi
meiocytes, 24 univalents were observed, and no histone H2AX phosphorylation foci were detected. Compared with the wild type, the number of 21-nucleotide small RNAs in
Osrdr6-mei
was dramatically lower, while the number of 24-nucleotide small RNAs was significantly higher. Thousands of differentially methylated regions (DMRs) were discovered in
Osrdr6-mei
, implying that OsRDR6 plays an important role in DNA methylation. There were 457 genes downregulated in
Osrdr6-mei
, including three genes,
CENTRAL REGION COMPONENT1
,
P31
comet
, and
O. sativa
SOLO
DANCERS
, related to DSB formation. Interestingly, the downregulated genes were associated with a high level of 24-nucleotide small RNAs but less strongly associated with DMRs. Therefore, we speculate that the alteration in expression of small RNAs in
Osrdr6
mutants leads to the defects in DSB formation during meiosis, which might not be directly dependent on RNA-directed DNA methylation.
...
PMID:
Oryza sativa
RNA-Dependent RNA Polymerase 6 Contributes to Double-Strand Break Formation in Meiosis. 3273 9
A novel reverse-
transcriptase
loop mediated amplification (RT-LAMP) method targeting genes encoding the Spike (S) protein and
RNA-dependent RNA polymerase
(RdRP) of SARS-CoV-2 has been developed. The LAMP assay achieves a comparable limit of detection (25-50 copies per reaction) to commonly used RT-PCR protocols using clinical samples quantified by digital droplet PCR. Precision, cross-reactivity, inclusivity, and limit of detection studies were performed according to regulatory standards. Clinical validation of dual-target RT-LAMP (S and RdRP gene) achieved a PPA of 98.48 % (95 % CI 91.84%-99.96%) and
NPA
100.00 % (95 % CI 93.84%-100.00%) based on the E gene and N2 gene reference RT-PCR methods. The method has implications for development of point of care technology using isothermal amplification.
...
PMID:Optimization and clinical validation of dual-target RT-LAMP for SARS-CoV-2. 3294 77